מתוטרקסאט אבווה 100 מגמל

Quốc gia: Israel

Ngôn ngữ: Tiếng Do Thái

Nguồn: Ministry of Health

Thành phần hoạt chất:

METHOTREXATE

Sẵn có từ:

NOVARTIS ISRAEL LTD

Mã ATC:

L01BA01

Dạng dược phẩm:

תרכיז להכנת תמיסה לאינפוזיה

Thành phần:

METHOTREXATE 100 MG/ML

Tuyến hành chính:

תוך-שרירי, תוך-עורקי, תוך-ורידי, תוך חדרי, תוך-שדרתי

Loại thuốc theo toa:

מרשם נדרש

Sản xuất bởi:

EBEWE PHARMA GES.M.B.H NFG.KG, AUSTRIA

Nhóm trị liệu:

METHOTREXATE

Khu trị liệu:

METHOTREXATE

Chỉ dẫn điều trị:

Antineoplastic chemotherapy: treatment of gestational choriocarcinoma, chorioadenoma destruents and hydatidiform mole. Palliation of acute lymphocytic leukemia. In the treatment and prophylaxis of meningeal leukemia. Greatest effect has been observed in palliation of acute lymphoblastic (stem cell) leukemias in children. In combination with other anticancer agents, Methotrexate may be used for the induction of remission, but is most commonly used in maintenance of induced remissions. Abitrexate may be used alone or in combination with other antineoplastics in the management of breast cancer, epidermoid cancers of the head and neck, lung cancer (particularly squamous cell and small cell types), bladder cancer and osteogenic cancer. Methotrexate is effective in the treatment of the advanced stages (III and IV Peter's Staging System) of lymphosarcoma, particularly in children, and in advanced cases of mycosis fungoides. Psoriasis: because of the high risk attending its use, Methotrexate is indicated only in the

Ngày ủy quyền:

2023-09-30